Researchers at UMass Medical School have found that Google Glass, a head-mounted streaming audio/video device, may be used to effectively extend bed-side toxicology consults to distant health care facilities to diagnose and manage patients with suspected cases of poisoning.
In their just-released Clinical Cancer Advances 2016: ASCO’s Annual Report on Progress Against Cancer the American Society of Clinical Oncology (ASCO) has today hailed cancer immunotherapy as the top cancer advance of the year.
While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics. The finding comes from “Cancer Statistics for Hispanics/Latinos,” a comprehensive report produced every three years by the American Cancer Society and published in CA: A Cancer Journal for Clinicians.
US-based Amgen has signed a strategic research collaboration and license agreement with Kite Pharma to develop and commercialise chimeric antigen receptor (CAR) T cell immunotherapies.
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d’Ivoire and Republic of Congo are detected only after they’ve become advanced. The study, by American Cancer Society researchers and the African Cancer Registry Network, appears early online in the medical journal The Breast.
The largest population genome sequencing effort to date is published today in Nature. A series of papers describing resources and application of the data is published at the same time in Nature, Nature Genetics, Bioinformatics and Nature Communications.
France-based TxCell and Switzerland's Ferring International have partnered with Trizell Holding to further enhance the development of TxCell's Ovasave to treat inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis.